MLchartDataset catalogue

Odomzo

Term · Oncology and biomedicine · MLC-T-ONC-006017

A drug used to treat locally advanced basal cell carcinoma (BCC) that has come back after surgery or radiation therapy. It is also used in patients who cannot be treated with surgery or radiation therapy. Odomzo is also being studied in the treatment of other types of cancer. Odomzo blocks a type of protein involved in tissue growth and repair and may block the growth of cancer cells. It is a type of hedgehog signaling pathway antagonist. Also called erismodegib, LDE225, and sonidegib phosphate.

Table 1. Record
IdentifierMLC-T-ONC-006017
FieldOncology and biomedicine
Synonymserismodegib; LDE225; sonidegib phosphate
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-006017",
  "term": "Odomzo",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat locally advanced basal cell carcinoma (BCC) that has come back after surgery or radiation therapy. It is also used in patients who cannot be treated with surgery or radiation therapy. Odomzo is also being studied in the treatment of other types of cancer. Odomzo blocks a type of protein involved in tissue growth and repair and may block the growth of cancer cells. It is a type of hedgehog signaling pathway antagonist. Also called erismodegib, LDE225, and sonidegib phosphate.",
  "synonyms": [
    "erismodegib",
    "LDE225",
    "sonidegib phosphate"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/odomzo/"
}

Record 12,095 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.